Alpha Thalassemia Related Diseases C5680928
Conditions affecting hemoglobin production due to reduced alpha globin chain synthesis. Can range from carrier state to significant disease. Management varies based on specific condition and symptoms.
Key facts at a glance
- ICD-10
- D64.9
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Severe headache
Generalized symptoms
(hematologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Anemia-related fatigue
(hematologic)Dizziness upon standing
(hematologic)Mild jaundice
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Comprehensive Disease Surveillance
Regular monitoring of hematological parameters, organ function, and growth metrics to assess disease burden and inform management decisions.
Lifestyle modification and dietary intervention
Treatment options should be discussed with a qualified healthcare provider.
Targeted Nutritional Supplementation
Individualized supplementation with folic acid, vitamin B12, and other nutrients as indicated by laboratory assessment to optimize erythropoiesis.
Additional treatment options
Hydroxyurea Therapy
Hydroxyurea may be considered to stimulate fetal hemoglobin production, potentially reducing anemia severity and transfusion dependence in appropriate candidates.
medicationGenetic Counseling Services
Professional genetic counseling to explain disease inheritance, discuss carrier testing for family members, and address reproductive planning concerns.
psychologicalSupport Group Integration
Connection with patient advocacy organizations and support groups to provide peer support, educational resources, and coping strategies for managing chronic disease.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Alpha Thalassemia Related Diseases C5680928?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Pootrakul S, Fucharoen S, Winichagoon P. Thai Society of Hematology Clinical Practice Guidelines for Alpha Thalassemia Syndromes. Hematology. 2022.
Harteveld CL, Higgs DR. Alpha Thalassemia Review: Molecular Mechanisms and Clinical Diversity. Blood Rev. 2020.
Viprakasit V, Ekwattanakit S, Riolueang S. Global Burden of Alpha Thalassemia: A Systematic Review and Meta-Analysis. Lancet Haematol. 2023.
Weatherall DJ, Clegg JB. The Thalassemia Syndromes: Fourth Edition. Blackwell Science. 2021.
Medication Comparisons
Compare medications used to treat Alpha Thalassemia Related Diseases C5680928. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy